Michael Baker
Patrimonio netto: 418 064 $ in data 31/05/2026
Patrimonio netto: 418 064 $ in data 31/05/2026
Michael Baker is currently Director at Radiopharm Theranostics (USA), Inc. and Investment Associate at Bioscience Managers Pty Ltd. Former roles include Chief Executive Officer, MD & Director at Arovella Therapeutics Ltd. from 2021 to 2026, Independent Non-Executive Director at Radiopharm Theranostics Ltd. from 2021 to 2024, and Senior Manager at Hexima Ltd. Education includes an MBA from Melbourne Business School and undergraduate and graduate degrees from La Trobe University, conferred in 2004 and 2009 respectively.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/05/2026 | 8.184.493 ( 0,68% ) | 418 064 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Analista di Private Equity | 01/11/2017 |
Radiopharm Theranostics (USA), Inc.
Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Amministratore Delegato | 04/05/2026 |
| RADIOPHARM THERANOSTICS LIMITED | Direttore/Membro del Consiglio | 26/03/2024 |
| HEXIMA LIMITED | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Melbourne Business School
Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hexima Ltd.
Hexima Ltd. BiotechnologyHealth Technology Engages in research and development of plant-derived proteins for treatment of fungal nail infections and provides commercial property services | Health Technology |
Arovella Therapeutics Ltd.
Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
LaTrobe University
LaTrobe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Radiopharm Theranostics Ltd.
Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
Radiopharm Theranostics (USA), Inc.
Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale